nitroblue tetrazolium has been researched along with Laryngeal Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kopeć, W; Kuźniar, JB | 1 |
| Balm, FJ; Drexhage, HA; Snow, GB; von Blomberg, ME | 1 |
2 other study(ies) available for nitroblue tetrazolium and Laryngeal Neoplasms
| Article | Year |
|---|---|
[Nitroblue-tetrazolium reduction test (NBT) in patients with laryngeal carcinoma (author's transl)].
Topics: Adult; Aged; Carcinoma; Humans; Laryngeal Neoplasms; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Nitroblue Tetrazolium; Phagocytes | 1980 |
Mononuclear phagocyte function in head and neck cancer: NBT-dye reduction, maturation and migration of peripheral blood monocytes.
Topics: Adult; Age Factors; Aged; Blood Cell Count; Carcinoma, Squamous Cell; Cell Differentiation; Cell Migration Inhibition; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Macrophages; Male; Middle Aged; Monocytes; Nitroblue Tetrazolium | 1982 |